Company
Last deal
$50M
Amount
Series A
Stage
09.04.2024
Date
2
all rounds
$64.3M
Total amount
General
About Company
Arnatar Therapeutics is a biopharmaceutical company that specializes in the development of novel nucleic acid medications.
Last funding type
Series A
IPO status
Private
Contacts
Phone number
Website URL